Regulus Therapeutics Inc (RGLS)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current RGLS market cap is 191.44M. The company's latest EPS is USD -0.6998 and P/E is -3.94.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -8.3M | -8.83M | -12.26M | -15.21M | -13.75M |
| Net Income | -8.06M | -8.47M | -11.04M | -14.06M | -12.79M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 10.01M | 0 | 0 | 0 | 0 |
| Operating Income | -14.16M | -27.82M | -28.24M | -31.11M | -50.04M |
| Net Income | -15.73M | -27.81M | -28.32M | -30.04M | -46.36M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 30.75M | 114.14M | 104.12M | 93.76M | 84.18M |
| Total Liabilities | 9.56M | 6.55M | 5.94M | 6.96M | 7.77M |
| Total Equity | 21.19M | 107.59M | 98.18M | 86.81M | 76.41M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 37.6M | 68.45M | 46.72M | 30.75M | 84.18M |
| Total Liabilities | 11.58M | 13.5M | 13.43M | 9.56M | 7.77M |
| Total Equity | 26.03M | 54.96M | 33.29M | 21.19M | 76.41M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -26.77M | -8.74M | -20.38M | -29.83M | -41.67M |
| Investing | 14.49M | -78.54M | -78.63M | -59.98M | -35.98M |
| Financing | 11.82M | 93.11M | 92.36M | 92.42M | 92.42M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -12.54M | -24.13M | -25.53M | -26.77M | -41.67M |
| Investing | -11k | -251k | -15.12M | 14.49M | -35.98M |
| Financing | 9.51M | 53.74M | 4.49M | 11.82M | 92.42M |
| Market Cap | 191.44M |
| Price to Earnings Ratio | -3.94 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4.75 |
| Price to Book Ratio | 2.39 |
| Dividend Yield | - |
| Shares Outstanding | 66.24M |
| Average Volume (1 week) | 1.08M |
| Average Volume (1 Month) | 2.76M |
| 52 Week Change | 26.20% |
| 52 Week High | 2.90 |
| 52 Week Low | 0.8301 |
| Spread (Intraday) | 0.02 (0.69%) |
| Company Name | Regulus Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.regulusrx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
